Literature DB >> 31273359

[Cost analysis and evaluation of a PET/CT system-department in a public Greek hospital].

Dimitra Kefallonitou1, Kyriakos Souliotis, Ioannis Datseris, Giagkos Lavranos, Eirini Polykarpou.   

Abstract

OBJECTIVE: Positron emission tomography/computed tomography (PET/CT) is an imaging technology that has experienced rapid development in recent years. The aim of this paper was to present the financial viability of a PET/CT department in a public hospital of Athens, Greece. This study performs a detailed financial analysis of the operating revenues and expenses of the department for the years 2007-2017. SUBJECTS AND METHODS: For each year considered, detailed analysis of incomes and expenses has been performed. During a normal working day 15 scans are acquired by the PET/CT department. Over the 11 years of operation, 22.035 scans had been performed in total. The turnover for the examined period reached €40.395.275 is this cumulative revenue over the 11 years.
RESULTS: The following 6 evaluation and decision-making methods are presented: a) Net present value of the investment 2.245.251€ (factor β beta 0,6923), b) Internal rate of return was estimated 34,89%, c) The payback period is achieved by 2011, d) The profitability index is 2,10, e) Average rate of return or accounting rate of return is 27,20%, and f) Return On Investment is estimated 299,25%.
CONCLUSION: Even if we have to consider that it is not proper to evaluate with financial terms health, it is concluded through the present study that the investment for settling and operating the under-examination PET/CT unit of the present public hospital was financially profitable.

Year:  2019        PMID: 31273359     DOI: 10.1967/s002449911010

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  1 in total

1.  Integrating a Positron Emission Tomography/Computed Tomography Into the National Health System of Cyprus: Will It Return on Its Investment?

Authors:  Dimitra Kefallonitou; Irene Polycarpou; Kyriakos Souliotis; Konstantinos Giannakou
Journal:  Front Public Health       Date:  2021-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.